Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Early epigenetic changes precede genetic alterations and drive hepatocarcinogenesis

ABSTRACT: Early epigenetic changes precede genetic alterations and drive hepatocarcinogenesis

PROVIDER: PRJNA609989 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Early epigenetic changes precede genetic alterations and drive hepatocarcinogenesis

Project description:genome-wide methylome and transcriptome profiling of cirrhotic liver, low- and high-grade dysplastic lesions, eHCC and pHCC synchronouCLy detected in HCC patients with chronic hepatitis B infection. Identification of molecular epi-drivers by integrative analyses and validation in two independent cohorts comprising 933 HCC.

2021-03-01 | GSE146286 | GEO

Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis.

Project description:Development of primary liver cancer is a multistage process. Detailed understanding of sequential epigenetic alterations is largely missing. Here, we performed Infinium Human Methylation 450k BeadChips and RNA-Seq analyses for genome-wide methylome and transcriptome profiling of cirrhotic liver (n = 7), low- (n = 4) and high-grade (n = 9) dysplastic lesions, and early (n = 5) and progressed (n = 3) hepatocellular carcinomas (HCC) synchronously detected in 8 patients with HCC with chronic hepatitis B infection. Integrative analyses of epigenetically driven molecular changes were identified and validated in 2 independent cohorts comprising 887 HCCs. Mitochondrial DNA sequencing was further employed for clonality analyses, indicating multiclonal origin in the majority of investigated HCCs. Alterations in DNA methylation progressively increased from liver cirrhosis (CL) to dysplastic lesions and reached a maximum in early HCCs. Associated early alterations identified by Ingenuity Pathway Analysis (IPA) involved apoptosis, immune regulation, and stemness pathways, while late changes centered on cell survival, proliferation, and invasion. We further validated 23 putative epidrivers with concomitant expression changes and associated with overall survival. Functionally, Striatin 4 (STRN4) was demonstrated to be epigenetically regulated, and inhibition of STRN4 significantly suppressed tumorigenicity of HCC cell lines. Overall, application of integrative genomic analyses defines epigenetic driver alterations and provides promising targets for potentially novel therapeutic approaches.

| S-EPMC8492348 | biostudies-literature

Gain-of-function genetic alterations of G9a drive oncogenesis

Project description:Gain-of-function genetic alterations of G9a drive oncogenesis

| PRJNA614536 | ENA

Gain-of-function genetic alterations of G9a drive oncogenesis I

Project description:Gain-of-function genetic alterations of G9a drive oncogenesis I

| PRJNA614522 | ENA

Gain-of-function genetic alterations of G9a drive oncogenesis II

Project description:Gain-of-function genetic alterations of G9a drive oncogenesis II

| PRJNA614541 | ENA

Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis

Project description:Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis

| PRJNA955797 | ENA

Identification of aging-associated gene expression signatures that precede intestinal tumorigenesis [human]

Project description:Aging-associated gene expression alterations have been implicated in various cancers including colorectal cancer. We examined aging-associated gene expression signatures that precede intestinal tumorigenesis using surgical specimens of Japanese FAP patients.

2016-05-03 | GSE80981 | GEO

Mapping alterations spatially and temporally during early stages of breast tumourigenesis [aCGH]

Project description:Identifying genomic alterations that precede tumourigenesis of breast tumours will allow us to better understand tumour development and heterogeneity. In particular, by obtaining and profiling normal-epithelium samples at various distances from the tumour, we can draft both a spatial and temporal map of the genomic events and transcriptomic alterations that occur along the mammary duct (leading up to and including the tumour).

2017-11-02 | GSE72652 | GEO

Mapping alterations spatially and temporally during early stages of breast tumourigenesis [expression]

2017-11-02 | GSE72644 | GEO

Changes in adenoviral chromatin organization precede early gene activation

Project description:Changes in adenoviral chromatin organization precede early gene activation

| PRJNA562677 | ENA